Compare Heron Therapeutics Inc (HRTX) vs Vanguard Real Estate Index Fund ETF (VNQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Vanguard Real Estate Index Fund ETF — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while Vanguard Real Estate Index Fund ETF trades at $99.54. The key difference: Vanguard Real Estate Index Fund ETF is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | VNQ | |
|---|---|---|
Market Cap | $91.46M | — |
Sector | Health | — |
52-Week High | $1.96 | $100.07 |
52-Week Low | $0.39 | $87.00 |
Enterprise Value | $189.36M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
VNQ trades at $99.5, down 0.52% on the day, with a bullish technical signal driven by strong moving average alignment. The ETF's expense ratio of 0.13% remains a competitive advantage, and recent news highlights its 12% year-to-date total return through mid-July 2026. Dividend payments are scheduled, with the next payout of $0.86 set for June 26, 2026.
Outlook is cautiously optimistic, supported by technical strength and cost efficiency, but risks include sensitivity to interest rates and potential overbought conditions. The ETF's domestic focus offers stability, yet investors should weigh the impact of Treasury yield fluctuations on real estate valuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Vanguard Real Estate Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Real Estate 25/50 Index, an index made up of stocks of large, mid-size, and small US companies within the real estate sector. The Advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VNQ →
